Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT03820986
Brief Title: Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advance Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)

First Submitted : January 22, 2019
First Submitted that Met QC Criteria : January 25, 2019
First Posted : January 29, 2019

Last Update Submitted that Met QC Criteria : January 17, 2020
Last Update Posted : January 21, 2020